Physician

Adam Antanas Kudirka, MD

According to 2025 Medicare claims, Adam Kudirka, MD (NPI: 1568922433) practices pulmonary disease in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Kent, MI. This provider's primary affiliated billing organization is ADVANTAGE HEALTH SAINT MARY'S MEDICAL GROUP (NPI: 1952340911; TIN: 272491974) and primary practice location at 49503-4693.

Kudirka's data goes back to 2015 and runs through 2024. Part D data shows 201 prescription claims across 44 beneficiaries totaling $73,505 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). Open Payments data shows 1 records totaling $140. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $10,621 and ending at $73,505. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.